Concepts (298)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 14 | 2020 | 465 | 3.960 |
Why?
|
| Monocytes | 13 | 2021 | 345 | 3.320 |
Why?
|
| Obesity | 20 | 2020 | 2235 | 2.700 |
Why?
|
| CD11c Antigen | 11 | 2021 | 35 | 2.460 |
Why?
|
| Atherosclerosis | 9 | 2019 | 835 | 2.150 |
Why?
|
| Insulin Resistance | 13 | 2021 | 644 | 2.070 |
Why?
|
| Inflammation | 13 | 2020 | 1404 | 1.560 |
Why?
|
| T-Lymphocytes | 7 | 2019 | 1693 | 1.280 |
Why?
|
| Fatty Acids | 2 | 2020 | 338 | 1.140 |
Why?
|
| Hypercholesterolemia | 5 | 2020 | 226 | 1.030 |
Why?
|
| Intra-Abdominal Fat | 3 | 2017 | 51 | 0.990 |
Why?
|
| Diet, High-Fat | 6 | 2020 | 212 | 0.980 |
Why?
|
| Panniculitis | 3 | 2016 | 19 | 0.970 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 69 | 0.870 |
Why?
|
| Foam Cells | 2 | 2019 | 20 | 0.790 |
Why?
|
| Apolipoproteins E | 7 | 2017 | 189 | 0.740 |
Why?
|
| Lipoprotein-X | 1 | 2020 | 3 | 0.720 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2021 | 387 | 0.710 |
Why?
|
| Diet, Western | 2 | 2019 | 17 | 0.710 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2018 | 195 | 0.700 |
Why?
|
| Macrophages | 3 | 2018 | 604 | 0.670 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2001 | 61 | 0.670 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 34 | 0.670 |
Why?
|
| Hypertriglyceridemia | 3 | 2017 | 100 | 0.640 |
Why?
|
| Myositis | 2 | 2017 | 51 | 0.640 |
Why?
|
| CD18 Antigens | 5 | 2017 | 49 | 0.630 |
Why?
|
| Weight Loss | 4 | 2011 | 481 | 0.630 |
Why?
|
| Lymphocyte Activation | 3 | 2021 | 684 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 20 | 2021 | 4368 | 0.590 |
Why?
|
| Immunity | 1 | 2018 | 179 | 0.580 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 65 | 0.570 |
Why?
|
| Muscle, Skeletal | 4 | 2017 | 941 | 0.570 |
Why?
|
| Cytokines | 3 | 2020 | 1282 | 0.560 |
Why?
|
| Metabolic Diseases | 2 | 2018 | 130 | 0.560 |
Why?
|
| Mice, Knockout | 17 | 2021 | 3727 | 0.550 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 97 | 0.550 |
Why?
|
| Animals | 32 | 2021 | 33850 | 0.540 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 350 | 0.540 |
Why?
|
| Proprotein Convertase 9 | 1 | 2017 | 69 | 0.540 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 79 | 0.540 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2017 | 84 | 0.520 |
Why?
|
| Dietary Supplements | 1 | 2020 | 475 | 0.520 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2013 | 61 | 0.520 |
Why?
|
| Mice | 26 | 2021 | 17556 | 0.500 |
Why?
|
| Cholesterol, VLDL | 1 | 2015 | 15 | 0.500 |
Why?
|
| Antigens, CD | 5 | 2001 | 420 | 0.500 |
Why?
|
| Blood Platelets | 5 | 2016 | 327 | 0.490 |
Why?
|
| Triglycerides | 4 | 2017 | 562 | 0.490 |
Why?
|
| Liver | 6 | 2012 | 1743 | 0.470 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 233 | 0.470 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 84 | 0.460 |
Why?
|
| Membrane Glycoproteins | 5 | 2001 | 413 | 0.460 |
Why?
|
| Aging | 2 | 2018 | 1185 | 0.460 |
Why?
|
| CD36 Antigens | 4 | 2019 | 35 | 0.450 |
Why?
|
| CD11a Antigen | 1 | 2013 | 10 | 0.450 |
Why?
|
| Aorta | 3 | 2020 | 541 | 0.450 |
Why?
|
| Interleukins | 1 | 2014 | 118 | 0.440 |
Why?
|
| Flow Cytometry | 6 | 2020 | 804 | 0.440 |
Why?
|
| Dietary Fats | 4 | 2014 | 296 | 0.430 |
Why?
|
| Aortic Diseases | 1 | 2015 | 198 | 0.410 |
Why?
|
| Lipoproteins, VLDL | 1 | 2012 | 58 | 0.400 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 4298 | 0.390 |
Why?
|
| CD11b Antigen | 3 | 2009 | 37 | 0.380 |
Why?
|
| Antibodies, Monoclonal | 5 | 2001 | 1010 | 0.380 |
Why?
|
| CD11 Antigens | 2 | 2017 | 12 | 0.380 |
Why?
|
| Integrin alpha Chains | 2 | 2017 | 15 | 0.380 |
Why?
|
| Phenotype | 2 | 2020 | 4227 | 0.370 |
Why?
|
| Dendritic Cells | 3 | 2021 | 402 | 0.370 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 26 | 0.360 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 42 | 0.350 |
Why?
|
| Endothelium, Vascular | 3 | 2021 | 516 | 0.320 |
Why?
|
| Piperidines | 1 | 2010 | 202 | 0.320 |
Why?
|
| Leukocytes | 1 | 2009 | 206 | 0.300 |
Why?
|
| Pyrazoles | 1 | 2010 | 305 | 0.290 |
Why?
|
| Adiponectin | 2 | 2013 | 109 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1877 | 0.290 |
Why?
|
| Humans | 30 | 2021 | 123259 | 0.290 |
Why?
|
| HIV Infections | 1 | 2019 | 1860 | 0.280 |
Why?
|
| Chemokine CCL5 | 1 | 2007 | 54 | 0.270 |
Why?
|
| Cells, Cultured | 5 | 2021 | 3044 | 0.270 |
Why?
|
| Adipocytes | 4 | 2020 | 158 | 0.270 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 850 | 0.260 |
Why?
|
| Chemokine CCL2 | 3 | 2011 | 114 | 0.260 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 233 | 0.250 |
Why?
|
| Weight Gain | 3 | 2013 | 400 | 0.240 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2020 | 63 | 0.240 |
Why?
|
| Body Weight | 1 | 2009 | 1007 | 0.240 |
Why?
|
| Male | 19 | 2020 | 60334 | 0.240 |
Why?
|
| Neoplasms | 1 | 2019 | 2758 | 0.230 |
Why?
|
| Superantigens | 1 | 2004 | 20 | 0.230 |
Why?
|
| Adiposity | 2 | 2018 | 191 | 0.230 |
Why?
|
| Platelet Activation | 3 | 1999 | 70 | 0.230 |
Why?
|
| Listeriosis | 1 | 2003 | 19 | 0.220 |
Why?
|
| Th1 Cells | 2 | 2021 | 152 | 0.200 |
Why?
|
| Spleen | 2 | 2018 | 272 | 0.190 |
Why?
|
| Interferon-gamma | 4 | 2021 | 502 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 473 | 0.190 |
Why?
|
| Lipoproteins, LDL | 2 | 2019 | 116 | 0.190 |
Why?
|
| Receptors, Fc | 1 | 2001 | 28 | 0.180 |
Why?
|
| Metabolic Syndrome | 3 | 2016 | 329 | 0.180 |
Why?
|
| Interleukin-5 | 1 | 2020 | 44 | 0.180 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 14 | 0.180 |
Why?
|
| Time Factors | 4 | 2015 | 6223 | 0.170 |
Why?
|
| Integrin alpha4beta1 | 2 | 2020 | 17 | 0.170 |
Why?
|
| Kupffer Cells | 1 | 2020 | 19 | 0.170 |
Why?
|
| Platelet Aggregation | 2 | 1999 | 120 | 0.170 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 71 | 0.170 |
Why?
|
| Hepatitis | 1 | 2020 | 59 | 0.160 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2019 | 15 | 0.160 |
Why?
|
| Membrane Microdomains | 2 | 2016 | 60 | 0.160 |
Why?
|
| Models, Immunological | 1 | 2018 | 35 | 0.160 |
Why?
|
| Postprandial Period | 2 | 2016 | 77 | 0.150 |
Why?
|
| CD47 Antigen | 1 | 2018 | 7 | 0.150 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 577 | 0.150 |
Why?
|
| Blotting, Western | 1 | 2020 | 1102 | 0.150 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 237 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2021 | 4497 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1289 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 89 | 0.140 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 23 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2019 | 331 | 0.140 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 143 | 0.140 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1687 | 0.140 |
Why?
|
| Blood Vessels | 1 | 2017 | 102 | 0.140 |
Why?
|
| Female | 13 | 2020 | 65617 | 0.140 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 216 | 0.140 |
Why?
|
| Lipid Droplets | 1 | 2017 | 46 | 0.140 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 69 | 0.140 |
Why?
|
| Cell Line | 3 | 2020 | 2771 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 268 | 0.130 |
Why?
|
| Cell Movement | 2 | 2017 | 831 | 0.130 |
Why?
|
| Glycosphingolipids | 1 | 2016 | 12 | 0.130 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2016 | 40 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2009 | 2816 | 0.130 |
Why?
|
| Glucose | 2 | 2020 | 880 | 0.130 |
Why?
|
| Drugs, Chinese Herbal | 1 | 1996 | 19 | 0.130 |
Why?
|
| Receptors, Ghrelin | 1 | 2016 | 29 | 0.130 |
Why?
|
| Macrophages, Peritoneal | 1 | 2016 | 38 | 0.130 |
Why?
|
| Blood Glucose | 3 | 2021 | 1123 | 0.130 |
Why?
|
| Calcium | 3 | 2001 | 1098 | 0.130 |
Why?
|
| Carrier Proteins | 1 | 2021 | 1022 | 0.130 |
Why?
|
| Macrophage Activation | 2 | 2020 | 62 | 0.130 |
Why?
|
| Cholesterol, Dietary | 1 | 2015 | 46 | 0.120 |
Why?
|
| Up-Regulation | 4 | 2017 | 862 | 0.120 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 77 | 0.120 |
Why?
|
| Receptors, LDL | 1 | 2015 | 89 | 0.120 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 120 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 389 | 0.120 |
Why?
|
| Age Factors | 2 | 2018 | 2811 | 0.120 |
Why?
|
| Cell Adhesion | 2 | 2015 | 318 | 0.110 |
Why?
|
| Osteonectin | 1 | 2013 | 6 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 750 | 0.110 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 33 | 0.110 |
Why?
|
| Lymphopenia | 1 | 2014 | 36 | 0.110 |
Why?
|
| Mice, Obese | 1 | 2013 | 78 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 560 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2013 | 60 | 0.110 |
Why?
|
| Adult | 6 | 2020 | 29100 | 0.110 |
Why?
|
| Interleukin-12 | 1 | 2013 | 113 | 0.110 |
Why?
|
| Interleukin-17 | 1 | 2014 | 118 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2314 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2014 | 90 | 0.100 |
Why?
|
| Palmitic Acid | 1 | 2012 | 35 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 254 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 109 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2525 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3239 | 0.090 |
Why?
|
| Metalloendopeptidases | 1 | 2011 | 100 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 41 | 0.090 |
Why?
|
| Thrombosis | 1 | 2016 | 518 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 1993 | 198 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1237 | 0.090 |
Why?
|
| Dyslipidemias | 1 | 2013 | 228 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2011 | 85 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4511 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 667 | 0.090 |
Why?
|
| Insulin | 2 | 2013 | 1208 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 178 | 0.080 |
Why?
|
| E-Selectin | 1 | 2009 | 42 | 0.080 |
Why?
|
| Chemokines | 1 | 2009 | 136 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 90 | 0.080 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 107 | 0.080 |
Why?
|
| Energy Intake | 1 | 2010 | 490 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 810 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 2053 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 174 | 0.070 |
Why?
|
| Protein Conformation | 2 | 1999 | 833 | 0.070 |
Why?
|
| Chemotactic Factors | 1 | 2007 | 17 | 0.070 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 29 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 796 | 0.070 |
Why?
|
| CD3 Complex | 1 | 2007 | 84 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2020 | 15 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1915 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1584 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 28 | 0.060 |
Why?
|
| Diet | 2 | 2010 | 1136 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 19198 | 0.060 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 56 | 0.060 |
Why?
|
| Ionomycin | 1 | 2004 | 15 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 68 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2004 | 82 | 0.060 |
Why?
|
| Middle Aged | 3 | 2020 | 26091 | 0.060 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 29 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 89 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2004 | 328 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 262 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2003 | 247 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 319 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 967 | 0.050 |
Why?
|
| Neutrophils | 1 | 2003 | 372 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2021 | 103 | 0.050 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 42 | 0.050 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2020 | 9 | 0.050 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 12 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 25 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 68 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2003 | 372 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 48 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 2953 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 150 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1999 | 29 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 659 | 0.040 |
Why?
|
| Adolescent | 1 | 2017 | 19127 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 1996 | 87 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 287 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 999 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 499 | 0.040 |
Why?
|
| Talin | 1 | 2018 | 8 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 738 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2020 | 458 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 2398 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 159 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1093 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1385 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 526 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 543 | 0.030 |
Why?
|
| Peritonitis | 1 | 2017 | 76 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2020 | 233 | 0.030 |
Why?
|
| Binding Sites | 1 | 1999 | 1291 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2020 | 527 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 97 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 683 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 157 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 38 | 0.030 |
Why?
|
| Paxillin | 1 | 2015 | 10 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 63 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2015 | 13 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2015 | 32 | 0.030 |
Why?
|
| Microfluidics | 1 | 2015 | 18 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 31 | 0.030 |
Why?
|
| Lipolysis | 1 | 2016 | 82 | 0.030 |
Why?
|
| Cell Plasticity | 1 | 2016 | 32 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 774 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 482 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 81 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 325 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 196 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 619 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 275 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 12 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 292 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2013 | 1553 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2014 | 60 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 79 | 0.030 |
Why?
|
| Epitopes | 1 | 1995 | 430 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12170 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1996 | 257 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 61 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 280 | 0.030 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2014 | 82 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 1993 | 100 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1993 | 41 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2014 | 172 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 153 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2013 | 196 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 300 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1741 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2014 | 222 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 395 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1993 | 111 | 0.020 |
Why?
|
| ADAMTS13 Protein | 1 | 2011 | 62 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 569 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1497 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2010 | 31 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 346 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2010 | 177 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1137 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1566 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1682 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 12 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2005 | 129 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3079 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3384 | 0.020 |
Why?
|
| Species Specificity | 1 | 2005 | 550 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 516 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 568 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7129 | 0.010 |
Why?
|